Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

MEP animal testing vote angers welfare groups

April 7, 2009 Research and Development, Sales and Marketing Animal testing, Europe, preclinical

The European Parliament's Agriculture and Rural Development Committee has been accused of watering down proposals drawn up by the European …
News

A new approach to CRO partnerships

April 6, 2009 Research and Development Pfizer, UK, clincal, partnerships

Contract research organisations now play an indispensable role in helping pharmaceutical companies develop their drugs. But as the number and …
Feature

Lilly forges risk-sharing R&D alliance with India’s Zydus

April 6, 2009 Research and Development Asia, India, lilly

Eli Lilly has forged a research collaboration with India's Zydus Cadila that sees the two companies combine their efforts in …
News

Consolidation wave expected in contract manufacturing

April 6, 2009 Research and Development CRO

The mergers and acquisitions that have become a feature of the contract research organisation (CRO) sector in recent years look …
News

Pfizer halts Sutent head-to-head trial

April 6, 2009 Research and Development, Sales and Marketing Cancer, Pfizer, Sutent

Pfizer has halted a late-stage breast cancer trial between Sutent and Roche's Xeloda, after the study failed to show significant …
News

Working Life: Maneesh Juneja

April 3, 2009 Research and Development GSK, productivity

How did you find your way into your current role? After graduating with a degree in business & computing, I …
Feature

Telehealth awareness reaches tipping point

April 2, 2009 Research and Development, Sales and Marketing digi, healthcare

Analysts Datamonitor believe that telehealth has reached the tipping point in terms of awareness, with IBM following Intel's entrance into …
News

Takeda chooses US base for its global development headquarters

April 2, 2009 Research and Development Takeda

Takeda Pharmaceutical Company is shifting its global development HQ from Japan to the US. The move will see that function …
News

CROs under pressure as early-stage pipelines dry up

March 27, 2009 Research and Development Pharmsource

There was a sharp slowdown in pharmaceutical outsourcing in the last six months which "really caught a lot of people …
News

GSK pledges further trial transparency

March 26, 2009 Research and Development, Sales and Marketing GSK

GlaxoSmithKline is to make its clinical trials more transparent through a series of moves it believes will facilitate clinical research. …
News

NICE recommends Pfizer’s Sutent

March 26, 2009 Research and Development NICE, Pfizer, Sutent

NICE has issued its final guidance on Pfizer's Sutent, recommending the kidney cancer drug as a first-line treatment. The drug …
News

GlaxoSmithKline and UCL to develop biologic

March 24, 2009 Research and Development GSK

Researchers at University College London are to work with GlaxoSmithKline to develop a new treatment for the rare and often …
News

Merck Serono sets up biotech fund

March 24, 2009 Research and Development Merck Serono, biotech

Merck Serono has set up a venture capital fund to invest in emerging biotech companies working in its core therapy …
News

Biosimilars: time for an approval pathway in the US

March 23, 2009 Research and Development, Sales and Marketing US, generics

Congress has received another bill seeking to establish a biosimilars approval pathway in the US. HR 1427 represents the latest …
News

Bayer strikes R&D deal with Chinese university

March 20, 2009 Research and Development Bayer, China, academic research

 Bayer has furthered its R&D expansion in China with an agreement to form a joint pharmaceutical research centre with Tsinghua …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026